QR kód

Development and validation of an immune signature-based risk model for prognostic assessment in melanoma

Abstract Melanoma is a highly invasive malignancy with poor prognoses in advanced stages. Developing a risk model that can accurately assess prognosis and guide personalized treatment is crucial for improving the clinical management of melanoma. This study aims to develop and validate an immune-base...

Celý popis

Uloženo v:
Hlavní autoři: Rui Tao, Jingjing Ruan, Xuejie Chen, Boshi Pang, Sicheng Li, Shengzhi Zhou, Sis Aghayants, Zeqi Shi, Zhanyong Zhu
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Portfolio 2025-03-01
Edice:Scientific Reports
Témata:
Melanoma
Prognosis
Immune
Tumor microenvironment
Risk model
On-line přístup:https://doi.org/10.1038/s41598-025-90917-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky